<HTML>

<HEAD><TITLE></TITLE></HEAD>
<BODY>



<TABLE ALIGN=CENTER  BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH="100%">
 <TR style="font-size:1px">
  <TD WIDTH="100%" VALIGN=TOP>
  <P ALIGN=CENTER>&nbsp;</P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P ALIGN=CENTER><FONT SIZE=4><B>SECURITIES AND EXCHANGE COMMISSION</B></FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P ALIGN=CENTER><FONT SIZE=3><B>Washington,
  D.C. 20549</B></FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P ALIGN=CENTER><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P ALIGN=CENTER><FONT SIZE=5><B>FORM S-8</B></FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P ALIGN=CENTER><FONT SIZE=3><B>Registration
  Statement</B></FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P ALIGN=CENTER><FONT SIZE=3><B>Under</B></FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P ALIGN=CENTER><FONT SIZE=3><B>The
  Securities Act of 1933, as amended.</B></FONT></P>
  </TD>
 </TR>
</TABLE>

<BR>

<TABLE ALIGN=CENTER  BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH="100%">
 <TR style="font-size:1px">
  <TD WIDTH="100%" VALIGN=TOP>
  <P ALIGN=CENTER>&nbsp;</P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P ALIGN=CENTER><FONT SIZE=5><B>VISUALMED CLINICAL SOLUTIONS CORP.</B></FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P ALIGN=CENTER><FONT SIZE=2>(Exact name of registrant as specified in charter.)</FONT></P>
  </TD>
 </TR>
</TABLE>

<BR>

<TABLE ALIGN=CENTER  BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH="100%">
 <TR style="font-size:1px">
  <TD WIDTH="46%" VALIGN=TOP>
  <P ALIGN=CENTER>&nbsp;</P>
  </TD>
  <TD WIDTH="4%" VALIGN=TOP>
  <P>&nbsp;</P>
  </TD>
  <TD WIDTH="49%" VALIGN=TOP>
  <P>&nbsp;</P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P ALIGN=CENTER><FONT SIZE=2><B>Nevada</B></FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P ALIGN=CENTER><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P ALIGN=CENTER><FONT SIZE=2><B>88-0436055</B></FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P ALIGN=CENTER><FONT SIZE=2>(State or other jurisdiction or organization)</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P ALIGN=CENTER><FONT SIZE=2>(I.R.S. Employer Identification Number)</FONT></P>
  </TD>
 </TR>
</TABLE>

<P ALIGN=CENTER><FONT  SIZE=2><B>VISUALMED CLINICAL SOLUTIONS CORP. <BR>
1035 Laurier W. Suite 200<BR>
Montreal, Quebec<BR>
Canada H2V 2L1<BR>
(514) 274-1115<BR></B>(Address and telephone of executive offices, including
zip code.)</FONT></P>

<P ALIGN=CENTER><FONT  SIZE=2><B>THE VISUALMED CLINICAL SOLUTIONS CORP.<BR>
2006 NONQUALIFIED STOCK OPTION PLAN</B></FONT></P>

<P ALIGN=CENTER><FONT  SIZE=2><B>Gerard Dab, Chairman &amp; CEO<BR>
VISUALMED CLINICAL SOLUTIONS CORP. <BR>
1035 Laurier W. Suite 200<BR>
Montreal, Quebec<BR>
Canada H2V 2L1<BR>
(514) 274-1115<BR></B>(Name, address and telephone of agent for service)</FONT></P>

<P><FONT SIZE=2>Copies of all
communications, including all communications sent to the agent for service,
should be sent to:</FONT></P>

<P ALIGN=CENTER><FONT  SIZE=2><B>Stewart A. Merkin, Esq.<BR>
Law Office of Stewart A. Merkin, P.A.<BR>
Rivergate Plaza, Suite 300</B></FONT></P>

<HR NOSHADE ALIGN=CENTER WIDTH="100%" SIZE=4><P ALIGN=LEFT STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P><PAGE>

<P ALIGN=CENTER><FONT  SIZE=2><B>444 Brickell Avenue<BR>
Miami, FL 33131<BR>
Tel. (305)357-5556<BR>
Fax (305)358-2490</B></FONT></P>

<P ALIGN=CENTER><FONT  SIZE=2><B>CALCULATION OF REGISTRATION FEE</B></FONT></P>

<TABLE ALIGN=CENTER  BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH="100%">
 <TR style="font-size:1px">
  <TD WIDTH="37%" VALIGN=BOTTOM>
  <P>&nbsp;</P>
  </TD>
  <TD WIDTH="2%" VALIGN=BOTTOM>
  <P>&nbsp;</P>
  </TD>
  <TD WIDTH="1%" VALIGN=BOTTOM>
  <P>&nbsp;</P>
  </TD>
  <TD WIDTH="9%" VALIGN=BOTTOM>
  <P ALIGN=RIGHT>&nbsp;</P>
  </TD>
  <TD WIDTH="4%" VALIGN=BOTTOM>
  <P>&nbsp;</P>
  </TD>
  <TD WIDTH="1%" VALIGN=BOTTOM>
  <P>&nbsp;</P>
  </TD>
  <TD WIDTH="8%" VALIGN=BOTTOM>
  <P ALIGN=RIGHT>&nbsp;</P>
  </TD>
  <TD WIDTH="4%" VALIGN=BOTTOM>
  <P>&nbsp;</P>
  </TD>
  <TD WIDTH="1%" VALIGN=BOTTOM>
  <P>&nbsp;</P>
  </TD>
  <TD WIDTH="11%" VALIGN=BOTTOM>
  <P ALIGN=RIGHT>&nbsp;</P>
  </TD>
  <TD WIDTH="4%" VALIGN=BOTTOM>
  <P>&nbsp;</P>
  </TD>
  <TD WIDTH="1%" VALIGN=BOTTOM>
  <P>&nbsp;</P>
  </TD>
  <TD WIDTH="9%" VALIGN=BOTTOM>
  <P ALIGN=RIGHT>&nbsp;</P>
  </TD>
  <TD WIDTH="1%" VALIGN=BOTTOM>
  <P>&nbsp;</P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=BOTTOM>
  <P ALIGN=CENTER><FONT SIZE="1"><B>Title of Each Class of<BR>Securities to be<BR>Registered</B> </FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P ALIGN=CENTER><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P ALIGN=CENTER><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P ALIGN=CENTER><FONT SIZE=1><B>Amount to be<BR>
  Registered</B></FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P ALIGN=CENTER><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  COLSPAN="2" VALIGN=BOTTOM nowrap>
  <P ALIGN=CENTER><FONT SIZE=1><B>Aggregate Proposed<BR>
  Maximum Offering<BR>
  Price per Unit/Share</B></FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P ALIGN=CENTER><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  COLSPAN="2" VALIGN=BOTTOM>
  <P ALIGN=CENTER><FONT SIZE=1><B>Proposed Maximum<BR>
  Aggregate Offering<BR>
  Price [1]</B></FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P ALIGN=CENTER><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  COLSPAN="2" VALIGN=BOTTOM>
  <P ALIGN=CENTER><FONT SIZE=1><B>Amount of<BR>
  Registration<BR>
  Fee [2]</B></FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P ALIGN=CENTER><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=BOTTOM>
  <P ALIGN=CENTER><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>

 <TR>
  <TD  VALIGN=BOTTOM BGCOLOR="#E6E6E6">
  <P STYLE='MARGIN-LEFT:8.65PT;TEXT-INDENT:-8.65PT'><FONT    SIZE=2>Common Shares,
        $0.00001 par value, issuable upon exercise of stock options by Grantees</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM BGCOLOR="#E6E6E6">
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM BGCOLOR="#E6E6E6">
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM BGCOLOR="#E6E6E6">
  <P ALIGN=RIGHT><FONT SIZE=2>2,500,000</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM BGCOLOR="#E6E6E6">
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM BGCOLOR="#E6E6E6">
  <P><FONT SIZE=2>$</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM BGCOLOR="#E6E6E6">
  <P ALIGN=RIGHT><FONT SIZE=2>2.10 [1</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM BGCOLOR="#E6E6E6">
  <P><FONT SIZE=2>]</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM BGCOLOR="#E6E6E6">
  <P><FONT SIZE=2>$</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM BGCOLOR="#E6E6E6">
  <P ALIGN=RIGHT><FONT SIZE=2>5,250,000</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM BGCOLOR="#E6E6E6">
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM BGCOLOR="#E6E6E6">
  <P><FONT SIZE=2>$</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM BGCOLOR="#E6E6E6">
  <P ALIGN=RIGHT><FONT SIZE=2>561.75</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM BGCOLOR="#E6E6E6">
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P ALIGN=RIGHT><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P ALIGN=RIGHT><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P ALIGN=RIGHT><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P ALIGN=RIGHT><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=2>Totals</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P ALIGN=RIGHT><FONT SIZE=2>2,500,000</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=2>$</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P ALIGN=RIGHT><FONT SIZE=2>2.10</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=2>$</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P ALIGN=RIGHT><FONT SIZE=2>5,250,000</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=2>$</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P ALIGN=RIGHT><FONT SIZE=2>561.75</FONT></P>
  </TD>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
</TABLE>

<BR>

<TABLE ALIGN=CENTER  BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH="100%">
 <TR style="font-size:1px">
  <TD WIDTH="5%" VALIGN=TOP>
  <P>&nbsp;</P>
  </TD>
  <TD WIDTH="95%" VALIGN=TOP>
  <P>&nbsp;</P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>[1]
  Estimated solely for the purpose of calculating the registration fee pursuant
  to paragraphs (c) and (h) of Rule 457 under the Securities Act, as amended,
  based upon the average of the closing bid and ask prices for common shares,
  as quoted by the OTC Bulletin Board on February 24, 2006.</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>[2] The registration fee relating to this filing is $561.75,
        of which $254.01 has previously been paid. In reliance on Rule 457(b)
        of the Securities Act, as amended, the registrant is applying excess fees
        paid in connection with its Registration Statement on Form SB-2 (Registration
        No. 333-125348).</FONT></P>
  </TD>
 </TR>
</TABLE>

<P><FONT SIZE=2>In addition, pursuant to rule 416(c) under the Securities Act
  of 1933 (the &#8220;Act&#8221;), this registration statement also covers an
  indeterminate amount of interests to be offered or sold pursuant to the employee
  benefit plan described herein.</FONT></P>

<P><FONT SIZE=2><B>PART I. INFORMATION REQUIRED IN THE SECTION
10(a) PROSPECTUS. </B></FONT></P>

<P><FONT SIZE=2><B>ITEM 1. PLAN INFORMATION</B></FONT></P>

<P><FONT SIZE=2>See Item 2
below. </FONT></P>

<P><FONT SIZE=2><B>ITEM 2. REGISTRANT INFORMATION AND EMPLOYEE
PLAN ANNUAL INFORMATION. </B></FONT></P>

<P><FONT SIZE=2>The document containing the information specified in Part I of
  this registration statement on Form S-8 will be sent or given to participants
  in the Plan as specified by</FONT></P>

<HR NOSHADE ALIGN=CENTER WIDTH="100%" SIZE=4><P ALIGN=LEFT STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P><PAGE>

<P><FONT SIZE=2>Rule 428(b)(1) under the Act, as amended. Such documents are not
  required to be, and are not being, filed by the Registrant with the Securities
  and Exchange Commission, either as part of this registration statement or as
  prospectuses or prospectus supplements pursuant to Rule 424 under the Act, as
  amended. Such documents, together with the documents incorporated by reference
  herein pursuant to Item 3 of Part II of this registration statement on Form
  S-8, constitute a prospectus that meets the requirements of Section 10(a) of
  the Act, as amended. </FONT></P>

<P><FONT SIZE=2>The documents
incorporated by reference in Item 3 of Part II of this registration statement
are incorporated by reference in the Section 10(a) prospectus, and are
available without charge, upon written or oral request to VisualMED Clinical
Solutions Corp., 1035 Laurier W., Suite 200, Montreal, Quebec Canada, H2V 2L1,
(514) 274-1115, Attention: Corporate Secretary. </FONT></P>

<P><FONT SIZE=2><B>PART II. INFORMATION REQUIRED IN THE
REGISTRATION STATEMENT. </B></FONT></P>

<P><FONT SIZE=2><B>ITEM 3. INCORPORATION OF DOCUMENTS BY
REFERENCE. </B></FONT></P>

<P><FONT SIZE=2>The following
documents are incorporated by reference into this registration statement, and made
a part hereof:</FONT></P>

<TABLE ALIGN=CENTER  BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH="100%">
  <TR style="font-size:1px">
    <TD WIDTH="5%" VALIGN=TOP> <P>&nbsp;</P></TD>
    <TD WIDTH="95%" VALIGN=TOP> <P>&nbsp;</P></TD>
  </TR>
  <TR>
    <TD  VALIGN=TOP> <P><FONT SIZE=1>&nbsp;</FONT></P></TD>
    <TD  VALIGN=TOP> <P><FONT SIZE=2>(a) The Registrant&#146;s Annual Report on
        Form 10-KSB/A for the fiscal year ended June 30, 2005;</FONT></P></TD>
  </TR>
  <TR>
    <TD  VALIGN=TOP> <P><FONT SIZE=1>&nbsp;</FONT></P></TD>
    <TD  VALIGN=TOP> <P><FONT SIZE=1>&nbsp;</FONT></P></TD>
  </TR>
  <TR>
    <TD  VALIGN=TOP> <P><FONT SIZE=1>&nbsp;</FONT></P></TD>
    <TD  VALIGN=TOP> <P><FONT SIZE=2>(b) The Registrant&#146;s Quarterly Report
        on Form 10-QSB/A for the quarter ended September 30, 2005;</FONT></P></TD>
  </TR>
  <TR>
    <TD  VALIGN=TOP> <P><FONT SIZE=1>&nbsp;</FONT></P></TD>
    <TD  VALIGN=TOP> <P><FONT SIZE=1>&nbsp;</FONT></P></TD>
  </TR>
  <TR>
    <TD  VALIGN=TOP> <P><FONT SIZE=1>&nbsp;</FONT></P></TD>
    <TD  VALIGN=TOP> <P><FONT SIZE=2>(c) The Registrant&#146;s Quarterly Report
        on Form 10-QSB for the quarter ended December 31, 2005;</FONT></P></TD>
  </TR>
  <TR>
    <TD  VALIGN=TOP> <P><FONT SIZE=1>&nbsp;</FONT></P></TD>
    <TD  VALIGN=TOP> <P><FONT SIZE=1>&nbsp;</FONT></P></TD>
  </TR>
  <TR>
    <TD  VALIGN=TOP> <P><FONT SIZE=1>&nbsp;</FONT></P></TD>
    <TD  VALIGN=TOP> <P><FONT SIZE=2>(d) The Registrant's Current Reports on Form
      8-K/A filed on October 14, 2005 and December 8, 2005 and Current Report
      on Form 8-K filed on November 15, 2005; and</FONT></P></TD>
  </TR>
  <TR>
    <TD  VALIGN=TOP> <P><FONT SIZE=1>&nbsp;</FONT></P></TD>
    <TD  VALIGN=TOP> <P><FONT SIZE=1>&nbsp;</FONT></P></TD>
  </TR>
  <TR>
    <TD  VALIGN=TOP> <P><FONT SIZE=1>&nbsp;</FONT></P></TD>
    <TD  VALIGN=TOP> <P><FONT SIZE=2>(e) All other reports filed pursuant to section
        13(a) or 15(d) of the Securities Exchange Act of 1934, since the end of
        the fiscal year covered by the Registrant&#146;s document referred to
        in (a) above.</FONT></P></TD>
  </TR>
</TABLE>

<P><FONT SIZE=2><B>ITEM 4. DESCRIPTION OF SECURITIES. </B></FONT></P>

<P><FONT SIZE=2><B>Common Stock</B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
authorized capital stock consists of 100,000,000 shares of common stock,
$0.00001 par value per share. The holders of our common stock: </FONT></P>

<TABLE ALIGN=CENTER  BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH="100%">
 <TR style="font-size:1px">
  <TD WIDTH="5%" VALIGN=TOP>
  <P>&nbsp;</P>
  </TD>
  <TD WIDTH="5%" VALIGN=TOP>
  <P>&nbsp;</P>
  </TD>
  <TD WIDTH="90%" VALIGN=TOP>
  <P>&nbsp;</P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>&#149;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>have equal
  ratable rights to dividends from funds legally available if and when declared
  by our board of directors;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>&#149;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>are entitled
  to share ratably in all of our assets available for distribution to holders
  of common stock upon liquidation, dissolution or winding up of our affairs;</FONT></P>
  </TD>
 </TR>
</TABLE>

<BR>
<HR NOSHADE ALIGN=CENTER WIDTH="100%" SIZE=4><P ALIGN=LEFT STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P><PAGE>
<BR>
<TABLE ALIGN=CENTER  BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH="100%">
 <TR style="font-size:1px">
  <TD WIDTH="5%" VALIGN=TOP>
  <P>&nbsp;</P>
  </TD>
  <TD WIDTH="5%" VALIGN=TOP>
  <P>&nbsp;</P>
  </TD>
  <TD WIDTH="90%" VALIGN=TOP>
  <P>&nbsp;</P>
  </TD>
 </TR>
<TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>&#149;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>do not have
  preemptive, subscription or conversion rights and there are no redemption or
  sinking fund provisions or rights; and</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>&#149;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>are entitled
  to one non-cumulative vote per share on all matters on which stockholders may
  vote.</FONT></P>
  </TD>
 </TR>
</TABLE>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
  of February 15, 2006, we had 44,094,991 shares of common stock outstanding.</FONT></P>

<P><FONT SIZE=2><B>Non-cumulative voting</B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Holders
of shares of our common stock do not have cumulative voting rights, which means
that the holders of more than 50% of the outstanding shares, voting for the election
of directors, can elect all of the directors to be elected, if they so choose,
and, in that event, the holders of the remaining shares will not be able to
elect any of our directors.</FONT></P>

<P><FONT SIZE=2><B>Cash dividends</B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have not declared any cash dividends in the last two fiscal years. We intend to
retain future earnings for use in our business and do not anticipate declaring
or paying any cash or stock dividends on shares of our common shares in the
near future. In addition, any determination to declare and pay dividends will
be made by our Board of Directors in light of our earnings, financial position,
capital requirements and other factors that our Board of Directors deems
relevant.</FONT></P>

<P><FONT SIZE=2><B>Warrants</B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of February 15, 2006, there are 728,643 warrants outstanding, of which 561,976
warrants are to purchase common stock at an exercise price of $1.25, and
166,667 warrants are to purchase common stock at an exercise price of $0.0001
per share. The warrants are immediately exercisable and these warrants are exercisable
for a period of twenty-four months after the date of issuance after which they
will expire if not exercised. See the section of this prospectus entitled
&#147;Selling Stockholders&#148; and &#147;Recent Sales of Unregistered Securities.&#148;</FONT></P>

<P><FONT SIZE=2><B>Anti-takeover provisions</B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
are no Nevada anti-takeover provisions that may have the effect of delaying or
preventing a change in control.</FONT></P>

<P><FONT SIZE=2><B>Stock transfer agent</B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
stock transfer agent for our securities is Pacific Stock Transfer Company, 500
East Warm Springs Road, Las Vegas, Nevada 89119 and its telephone number is
(702) 361-3033.</FONT></P>

<P><FONT SIZE=2><B>ITEM 5. INTEREST OF NAMED EXPERTS AND
COUNSEL.</B></FONT></P>

<P><FONT SIZE=2>Not
Applicable. </FONT></P>

<P><FONT SIZE=2><B>ITEM 6. INDEMNIFICATION OF DIRECTORS AND
OFFICERS.</B></FONT></P>

<HR NOSHADE ALIGN=CENTER WIDTH="100%" SIZE=4><P ALIGN=LEFT STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P><PAGE>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
our articles of incorporation and bylaws, we may indemnify an officer or
director who is made a party to any proceeding, including a lawsuit, because of
his position, if he acted in good faith and in a manner he reasonably believed
to be in our best interest. We may advance expenses incurred in defending a
proceeding. To the extent that the officer or director is successful on the
merits in a proceeding as to which he is to be indemnified, we must indemnify
him against all expenses incurred, including attorney&#146;s fees. With respect to a
derivative action, indemnity may be made only for expenses actually and
reasonably incurred in defending the proceeding, and if the officer or director
is judged liable, only by a court order. The indemnification is intended to be
to the fullest extent permitted by the laws of the State of Nevada. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insofar
  as indemnification for liabilities arising under the Act may be permitted to
  directors, officers and controlling persons of the small business issuer pursuant
  to the foregoing provisions, or otherwise, the small business issuer has been
  advised that in the opinion of the Securities Exchange Commission such indemnification
  is against public policy as expressed in the Act and is, therefore, unenforceable.</FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Regarding
indemnification for liabilities arising under the Act, which may be permitted
to directors or officers under Nevada law, we are informed that, in the opinion
of the Securities and Exchange Commission, indemnification is against public
policy, as expressed in the Act and is, therefore, unenforceable. </FONT></P>

<P><FONT SIZE=2><B>ITEM 7. EXEMPTION FROM REGISTRATION.</B></FONT></P>

<P><FONT SIZE=2>Not
Applicable. </FONT></P>

<P><FONT SIZE=2><B>ITEM 8. EXHIBITS.</B></FONT></P>

<TABLE ALIGN=CENTER  BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH="100%">
 <TR style="font-size:1px">
  <TD WIDTH="12%" VALIGN=TOP>
  <P>&nbsp;</P>
  </TD>
  <TD WIDTH="87%" VALIGN=TOP>
  <P>&nbsp;</P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>Exhibit 4.1</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>VisualMED
  Clinical Solutions Corp. 2006 Nonqualified Stock Option Plan</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>Exhibit 4.2</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>Form of
  Non-Qualified Stock Option Agreement</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>Exhibit 5.1</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>Opinion of
  Stewart A. Merkin, Esq., Attorney at Law</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>Exhibit 23.1</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>Consent of
  Stewart A. Merkin, Esq., (included in Exhibit 5.1)</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>Exhibit 23.2</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>Consent of
  Manning Elliott LLP, Independent Registered Public Accounting Firm</FONT></P>
  </TD>
 </TR>
</TABLE>

<P><FONT SIZE=2><B>ITEM 9. UNDERTAKINGS.</B></FONT></P>

<P><FONT SIZE=2>The
undersigned registrant hereby undertakes:</FONT></P>

<P><FONT SIZE=2>1. To file, during any period in which offers or sales are being
  made, a post-effective amendment to this registration statement; </FONT></P>

<P><FONT SIZE=2>2. To include any material information with respect to the plan
  of distribution not previously disclosed in the registration statement or any
  material change to such information in the registration statement;</FONT></P>

<HR NOSHADE ALIGN=CENTER WIDTH="100%" SIZE=4><P ALIGN=LEFT STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P><PAGE>

<P><FONT SIZE=2>2. That, for
the purpose of determining any liability under the Act, each
such post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering
thereof; and </FONT></P>

<P><FONT SIZE=2>3. To remove
from registration by means of a post-effective amendment any of the securities
being registered which remain unsold at the termination of the offering. </FONT></P>

<P><FONT SIZE=2>The
undersigned registrant hereby undertakes that, for the purposes of determining
any liability under the Act, each filing of the Registrant&#146;s
annual report pursuant to Section 13(a) or Section 15(d) of the Securities
Exchange Act of 1934 that is incorporated by reference in the registration
statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering
thereof.</FONT></P>

<HR NOSHADE ALIGN=CENTER WIDTH="100%" SIZE=4><P ALIGN=LEFT STYLE='PAGE-BREAK-BEFORE: ALWAYS'></P><PAGE>

<P ALIGN=CENTER><FONT  SIZE=2><B>SIGNATURES</B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the requirements of the Securities Act of 1933, the Registrant certifies
that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form S-8 and has duly caused this registration statement to be
signed on its behalf by the undersigned, thereunto duly authorized, in
Montreal, Quebec, Canada on March 1, 2006.</FONT></P>

<P ALIGN=CENTER><FONT  SIZE=2>VISUALMED CLINICAL SYSTEMS CORP.</FONT></P>

<TABLE ALIGN=CENTER  BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH="100%">
 <TR style="font-size:1px">
  <TD WIDTH="39%" VALIGN=TOP>
  <P>&nbsp;</P>
  </TD>
  <TD WIDTH="61%" VALIGN=TOP>
  <P><FONT SIZE=2>By:
  /s/Gerard Dab</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>Gerard Dab,</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>Principal
  Executive Officer</FONT></P>
  </TD>
 </TR>
</TABLE>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the requirements of the Securities Act of 1933, this registration statement
has been signed by the following persons in the capacities and on the dates
indicated.</FONT></P>

<TABLE ALIGN=CENTER  BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH="100%">
 <TR style="font-size:1px">
  <TD WIDTH="35%" VALIGN=TOP>
  <P>&nbsp;</P>
  </TD>
  <TD WIDTH="3%" VALIGN=TOP>
  <P>&nbsp;</P>
  </TD>
  <TD WIDTH="34%" VALIGN=TOP>
  <P>&nbsp;</P>
  </TD>
  <TD WIDTH="3%" VALIGN=TOP>
  <P>&nbsp;</P>
  </TD>
  <TD WIDTH="23%" VALIGN=TOP>
  <P>&nbsp;</P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1><B>Signature</B></FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1><B>Title</B></FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1><B>Date</B></FONT></P>
  </TD>
 </TR>

<TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>


 <TR>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=2>/s/ Gerard
  Dab</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>Principle
  Executive Officer, Secretary<BR>
  and a member of the Board of Directors</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>March 1,
  2006</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <HR SIZE=1 WIDTH="100%" NOSHADE  ALIGN=CENTER>

  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>Gerard Dab</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=bottom>
  <P><FONT SIZE=2>/s/ Arthur
  Gelston MD</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>President,
  Chief Science Officer and a<BR>
  member of the Board of Directors</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>March 1,
  2006</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <HR SIZE=1 WIDTH="100%" NOSHADE  ALIGN=CENTER>

  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>Arthur
  Gelston MD</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=2>/s/ Philippe
  Rainville</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>Principal
  Financial Officer, Principal<BR>
  Accounting Officer and Treasurer</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>March 1,
  2006</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=BOTTOM>
  <HR SIZE=1 WIDTH="100%" NOSHADE  ALIGN=CENTER>

  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=2>Philippe
  Rainville</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=2>/s/ Louis J.
  Lombardo</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>A member of
  the Board of Directors</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>March 1,
  2006</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=BOTTOM>
  <HR SIZE=1 WIDTH="100%" NOSHADE  ALIGN=CENTER>

  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=2>Louis J.
  Lombardo</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=2>/s/ Philippe
  Panzini</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>A member of
  the Board of Directors</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>March 1,
  2006</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=BOTTOM>
  <HR SIZE=1 WIDTH="100%" NOSHADE  ALIGN=CENTER>

  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=2>&nbsp;</FONT></P>
  </TD>
 </TR>
 <TR>
  <TD  VALIGN=BOTTOM>
  <P><FONT SIZE=2>Philippe
  Panzini</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
  <TD  VALIGN=TOP>
  <P><FONT SIZE=1>&nbsp;</FONT></P>
  </TD>
 </TR>
</TABLE>
<BR>
<HR NOSHADE ALIGN=CENTER WIDTH="100%" SIZE=4>



</BODY>

</HTML>
[{"type": "S-8", "sequence": "1", "filename": "a41459.htm", "description": "VISUALMED CLINICAL SOLUTIONS CORP.", "secsgml_size_bytes": 35424}]
{"company-data": {"conformed-name": "VisualMED Clinical Solutions Corp.", "cik": "0001102942", "assigned-sic": "7373", "irs-number": "880436055", "state-of-incorporation": "NV", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-132179", "film-number": "06661053"}, "business-address": {"street1": "1035 LAURIER STREET WEST", "city": "MONTREAL", "state": "A8", "zip": "H2V 2L1", "phone": "(514) 274-1115"}, "mail-address": {"street1": "1035 LAURIER STREET WEST", "city": "MONTREAL", "state": "A8", "zip": "H2V 2L1"}, "former-company": [{"former-conformed-name": "VisualMED Clinical Systems Corp.", "date-changed": "20050106"}, {"former-conformed-name": "ANCONA MINING CORP", "date-changed": "20000111"}]}
SECURITIES AND EXCHANGE COMMISSION
Washington,
  D.C. 20549
FORM S-8
Registration
  Statement
Under
The
  Securities Act of 1933, as amended.
VISUALMED CLINICAL SOLUTIONS CORP.
(Exact name of registrant as specified in charter.)
Nevada
88-0436055
(State or other jurisdiction or organization)
(I.R.S. Employer Identification Number)
VISUALMED CLINICAL SOLUTIONS CORP.
1035 Laurier W. Suite 200
Montreal, Quebec
Canada H2V 2L1
(514) 274-1115
(Address and telephone of executive offices, including
zip code.)
THE VISUALMED CLINICAL SOLUTIONS CORP.
2006 NONQUALIFIED STOCK OPTION PLAN
Gerard Dab, Chairman & CEO
VISUALMED CLINICAL SOLUTIONS CORP.
1035 Laurier W. Suite 200
Montreal, Quebec
Canada H2V 2L1
(514) 274-1115
(Name, address and telephone of agent for service)
Copies of all
communications, including all communications sent to the agent for service,
should be sent to:
Stewart A. Merkin, Esq.
Law Office of Stewart A. Merkin, P.A.
Rivergate Plaza, Suite 300
444 Brickell Avenue
Miami, FL 33131
Tel. (305)357-5556
Fax (305)358-2490
CALCULATION OF REGISTRATION FEE
Title of Each Class of
Securities to be
Registered
Amount to be
Registered
Aggregate Proposed
Maximum Offering
Price per Unit/Share
Proposed Maximum
Aggregate Offering
Price [1]
Amount of
Registration
Fee [2]
Common Shares,
        $0.00001 par value, issuable upon exercise of stock options by Grantees
2,500,000
$
2.10 [1
]
$
5,250,000
$
561.75
Totals
2,500,000
$
2.10
$
5,250,000
$
561.75
[1]
  Estimated solely for the purpose of calculating the registration fee pursuant
  to paragraphs (c) and (h) of Rule 457 under the Securities Act, as amended,
  based upon the average of the closing bid and ask prices for common shares,
  as quoted by the OTC Bulletin Board on February 24, 2006.
[2] The registration fee relating to this filing is $561.75,
        of which $254.01 has previously been paid. In reliance on Rule 457(b)
        of the Securities Act, as amended, the registrant is applying excess fees
        paid in connection with its Registration Statement on Form SB-2 (Registration
        No. 333-125348).
In addition, pursuant to rule 416(c) under the Securities Act
  of 1933 (the "Act"), this registration statement also covers an
  indeterminate amount of interests to be offered or sold pursuant to the employee
  benefit plan described herein.
PART I. INFORMATION REQUIRED IN THE SECTION
10(a) PROSPECTUS.
ITEM 1. PLAN INFORMATION
See Item 2
below.
ITEM 2. REGISTRANT INFORMATION AND EMPLOYEE
PLAN ANNUAL INFORMATION.
The document containing the information specified in Part I of
  this registration statement on Form S-8 will be sent or given to participants
  in the Plan as specified by
Rule 428(b)(1) under the Act, as amended. Such documents are not
  required to be, and are not being, filed by the Registrant with the Securities
  and Exchange Commission, either as part of this registration statement or as
  prospectuses or prospectus supplements pursuant to Rule 424 under the Act, as
  amended. Such documents, together with the documents incorporated by reference
  herein pursuant to Item 3 of Part II of this registration statement on Form
  S-8, constitute a prospectus that meets the requirements of Section 10(a) of
  the Act, as amended.
The documents
incorporated by reference in Item 3 of Part II of this registration statement
are incorporated by reference in the Section 10(a) prospectus, and are
available without charge, upon written or oral request to VisualMED Clinical
Solutions Corp., 1035 Laurier W., Suite 200, Montreal, Quebec Canada, H2V 2L1,
(514) 274-1115, Attention: Corporate Secretary.
PART II. INFORMATION REQUIRED IN THE
REGISTRATION STATEMENT.
ITEM 3. INCORPORATION OF DOCUMENTS BY
REFERENCE.
The following
documents are incorporated by reference into this registration statement, and made
a part hereof:
(a) The Registrant's Annual Report on
        Form 10-KSB/A for the fiscal year ended June 30, 2005;
(b) The Registrant's Quarterly Report
        on Form 10-QSB/A for the quarter ended September 30, 2005;
(c) The Registrant's Quarterly Report
        on Form 10-QSB for the quarter ended December 31, 2005;
(d) The Registrant's Current Reports on Form
      8-K/A filed on October 14, 2005 and December 8, 2005 and Current Report
      on Form 8-K filed on November 15, 2005; and
(e) All other reports filed pursuant to section
        13(a) or 15(d) of the Securities Exchange Act of 1934, since the end of
        the fiscal year covered by the Registrant's document referred to
        in (a) above.
ITEM 4. DESCRIPTION OF SECURITIES.
Common Stock
Our
authorized capital stock consists of 100,000,000 shares of common stock,
$0.00001 par value per share. The holders of our common stock:
•
have equal
  ratable rights to dividends from funds legally available if and when declared
  by our board of directors;
•
are entitled
  to share ratably in all of our assets available for distribution to holders
  of common stock upon liquidation, dissolution or winding up of our affairs;
•
do not have
  preemptive, subscription or conversion rights and there are no redemption or
  sinking fund provisions or rights; and
•
are entitled
  to one non-cumulative vote per share on all matters on which stockholders may
  vote.
As
  of February 15, 2006, we had 44,094,991 shares of common stock outstanding.
Non-cumulative voting
Holders
of shares of our common stock do not have cumulative voting rights, which means
that the holders of more than 50% of the outstanding shares, voting for the election
of directors, can elect all of the directors to be elected, if they so choose,
and, in that event, the holders of the remaining shares will not be able to
elect any of our directors.
Cash dividends
We
have not declared any cash dividends in the last two fiscal years. We intend to
retain future earnings for use in our business and do not anticipate declaring
or paying any cash or stock dividends on shares of our common shares in the
near future. In addition, any determination to declare and pay dividends will
be made by our Board of Directors in light of our earnings, financial position,
capital requirements and other factors that our Board of Directors deems
relevant.
Warrants
As
of February 15, 2006, there are 728,643 warrants outstanding, of which 561,976
warrants are to purchase common stock at an exercise price of $1.25, and
166,667 warrants are to purchase common stock at an exercise price of $0.0001
per share. The warrants are immediately exercisable and these warrants are exercisable
for a period of twenty-four months after the date of issuance after which they
will expire if not exercised. See the section of this prospectus entitled
"Selling Stockholders" and "Recent Sales of Unregistered Securities."
Anti-takeover provisions
There
are no Nevada anti-takeover provisions that may have the effect of delaying or
preventing a change in control.
Stock transfer agent
Our
stock transfer agent for our securities is Pacific Stock Transfer Company, 500
East Warm Springs Road, Las Vegas, Nevada 89119 and its telephone number is
(702) 361-3033.
ITEM 5. INTEREST OF NAMED EXPERTS AND
COUNSEL.
Not
Applicable.
ITEM 6. INDEMNIFICATION OF DIRECTORS AND
OFFICERS.
Under
our articles of incorporation and bylaws, we may indemnify an officer or
director who is made a party to any proceeding, including a lawsuit, because of
his position, if he acted in good faith and in a manner he reasonably believed
to be in our best interest. We may advance expenses incurred in defending a
proceeding. To the extent that the officer or director is successful on the
merits in a proceeding as to which he is to be indemnified, we must indemnify
him against all expenses incurred, including attorney's fees. With respect to a
derivative action, indemnity may be made only for expenses actually and
reasonably incurred in defending the proceeding, and if the officer or director
is judged liable, only by a court order. The indemnification is intended to be
to the fullest extent permitted by the laws of the State of Nevada.
Insofar
  as indemnification for liabilities arising under the Act may be permitted to
  directors, officers and controlling persons of the small business issuer pursuant
  to the foregoing provisions, or otherwise, the small business issuer has been
  advised that in the opinion of the Securities Exchange Commission such indemnification
  is against public policy as expressed in the Act and is, therefore, unenforceable.
Regarding
indemnification for liabilities arising under the Act, which may be permitted
to directors or officers under Nevada law, we are informed that, in the opinion
of the Securities and Exchange Commission, indemnification is against public
policy, as expressed in the Act and is, therefore, unenforceable.
ITEM 7. EXEMPTION FROM REGISTRATION.
Not
Applicable.
ITEM 8. EXHIBITS.
Exhibit 4.1
VisualMED
  Clinical Solutions Corp. 2006 Nonqualified Stock Option Plan
Exhibit 4.2
Form of
  Non-Qualified Stock Option Agreement
Exhibit 5.1
Opinion of
  Stewart A. Merkin, Esq., Attorney at Law
Exhibit 23.1
Consent of
  Stewart A. Merkin, Esq., (included in Exhibit 5.1)
Exhibit 23.2
Consent of
  Manning Elliott LLP, Independent Registered Public Accounting Firm
ITEM 9. UNDERTAKINGS.
The
undersigned registrant hereby undertakes:
1. To file, during any period in which offers or sales are being
  made, a post-effective amendment to this registration statement;
2. To include any material information with respect to the plan
  of distribution not previously disclosed in the registration statement or any
  material change to such information in the registration statement;
2. That, for
the purpose of determining any liability under the Act, each
such post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering
thereof; and
3. To remove
from registration by means of a post-effective amendment any of the securities
being registered which remain unsold at the termination of the offering.
The
undersigned registrant hereby undertakes that, for the purposes of determining
any liability under the Act, each filing of the Registrant's
annual report pursuant to Section 13(a) or Section 15(d) of the Securities
Exchange Act of 1934 that is incorporated by reference in the registration
statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering
thereof.
SIGNATURES
Pursuant
to the requirements of the Securities Act of 1933, the Registrant certifies
that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form S-8 and has duly caused this registration statement to be
signed on its behalf by the undersigned, thereunto duly authorized, in
Montreal, Quebec, Canada on March 1, 2006.
VISUALMED CLINICAL SYSTEMS CORP.
By:
  /s/Gerard Dab
Gerard Dab,
Principal
  Executive Officer
Pursuant
to the requirements of the Securities Act of 1933, this registration statement
has been signed by the following persons in the capacities and on the dates
indicated.
Signature
Title
Date
/s/ Gerard
  Dab
Principle
  Executive Officer, Secretary
and a member of the Board of Directors
March 1,
  2006
Gerard Dab
/s/ Arthur
  Gelston MD
President,
  Chief Science Officer and a
member of the Board of Directors
March 1,
  2006
Arthur
  Gelston MD
/s/ Philippe
  Rainville
Principal
  Financial Officer, Principal
Accounting Officer and Treasurer
March 1,
  2006
Philippe
  Rainville
/s/ Louis J.
  Lombardo
A member of
  the Board of Directors
March 1,
  2006
Louis J.
  Lombardo
/s/ Philippe
  Panzini
A member of
  the Board of Directors
March 1,
  2006
Philippe
  Panzini